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Abstract Female rats at various stages of pregnancy were in- 
jected intraperitoneally with ['Hlwater; 4 h later, they were 
killed, the uterus was removed, and the fetuses were dissected. 
Lipids were isolated and fractionated by HPLC and the total 
amount of cholesterol in each organ, as well as radioactivity 
incorporated into cholesterol and cholesterol precursors, 
were determined. From the data for cholesterol content at 
each age we calculated the rate of accumulation of cholesterol 
during fetal development. As incorporation of label from 
[ 3H]water takes place with a stoichiometry defined by a known 
biosynthetic pathway, we were also able to determine the frac- 
tion of cholesterol accumulating in each organ that had been 
newly synthesized. For the fetus as a whole, more than 93% of 
the cholesterol accumulating during development was newly 
synthesized.l As the specific radioactivity of cholesterol in 
the maternal circulation was negligible (because synthesis of 
cholesterol by maternal liver was suppressed by inclusion of 
cholesterol in the diet), we conclude that the fetus synthesizes 
nearly all of its own cholesterol; neither the maternal circula- 
tion nor the placenta/yolk sac contribute significant amounts 
of cholesterol to the fetus. We were also able to quantitate 
trafficking of cholesterol between fetal organs. Fetal brain is 
responsible for the synthesis of all of its own cholesterol. In 
contrast, fetal liver exports cholesterol into the fetal circula- 
tion and supplies about half of the cholesterol for devel- 
opment of heart, lung, and kidney.-Jurevics, H. A., F. Z. 
Kidwai, and P. MoreIl. Sources of cholesterol during develop- 
ment of the rat fetus and fetal organs. J. Lipid Res. 1997. 38: 
723-733 
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The developing fetus depends upon maternal circula- 
tion, as mediated by the placenta, for delivery of s u b  
strates for energy metabolism as well as precursors for 
biosynthesis of macromolecules needed during the pe- 
riod of rapid growth and development in utero. How- 
ever, molecules in the maternal circulation are not all 
equally available to the developing fetus, as the placenta 
exercises considerable control over what enters. A ques- 
tion arising is the extent to which cholesterol in the ma- 
ternal circulation, itself a pool containing cholesterol 
of dietary origin as well as that synthesized by the liver, 
can be utilized by the fetus. 
The origin of fetal cholesterol has been considered 
previously. There are a number of lines of evidence 
which suggest that in several species the dam contrib- 
utes considerable cholesterol to the fetus (1-3). We 
have investigated the source of fetal cholesterol in rat 
and arrive at a contradictory conclusion. Our approach 
is based on an experimental method exploited by Spady 
and Dietschy (4, 5). When ['Hlwater is injected into 
animals there is rapid equilibration of label with the 
whole body pool of water. The tritium atoms from this 
water are incorporated into cholesterol in a stoichiome- 
try defined by known biosynthetic pathways. This allows 
for determination of the absolute rate of cholesterol 
biosynthesis in vivo. Belknap and Dietschy (6) extended 
this methodology to the study of pregnant rats. They 
showed that the rate of synthesis of cholesterol was sev- 
eral fold higher in the fetus than in the mother, and 
that dietary cholesterol repressed maternal hepatic cho- 
lesterol synthesis, but did not greatly affect synthesis of 
cholesterol in the fetus. They also found that while the 
placenta took up Iz5I-labeled cellobiose-labeled low den- 
sity lipoprotein, none of the apolipoproteins or choles- 
terol was transferred to the fetus. This suggested that 
much of the fetal cholesterol is synthesized within the 
fetus. 
We have further extended these studies by quantita- 
tive correlation of the rate of cholesterol synthesis in 
the fetus with the rate of accumulation of total choles- 
terol. This allows us to reliably quantitate the fraction 
of total fetal cholesterol that is synthesized in the fetus. 
An extension of this methodology has allowed us to 
study trafficking of cholesterol among different fetal or- 
gans as a function of development. Of particular inter- 
est is whether the liver of the fetus is a net exporter of 
cholesterol, and which developing tissues utilize choles- 
terol produced by the liver. A specific question is 
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whether developing brain relies on the fetal circulation 
as a significant source of cholesterol. This is relevant in 
relation to the recent elucidation of the metabolic de- 
fect in Smith-Lemli-Opitz syndrome. In this autosomal 
recessive disorder cholesterol synthesis is impaired at 
the level of 7-dehydrocholesterol-A7-red~ictase (7, 8 ) .  
The nature of this defect has led to the suggestion that 
elevating circulating cholesterol levels in the mother 
during pregnancy (or perhaps by surgically mediated 
delivery of cholesterol to the fetal circulation) might 
alleviate some of the problems of brain development 
caused by this disorder (9, 10). Such treatment would 
only be useful if cholesterol could enter fetal brain from 
the fetal circulation. 
METHODS 
Animal model and tissue dissection 
To minimize variations in fetal numbers and fetal 
weights within and among litters, Long-Evans hooded 
rats in their second pregnancy were purchased from 
Charles River Breeding Laboratories (Raleigh, NC:) . 
Eight dams, timed pregnant to within a 12-h window, 
were obtained 7 days after mating. Upon arrival at our 
facility they were placed in individual cages and kept on 
a 12-h light/dark cycle at constant humidity (50 -+ 
10%) and temperature (21 t 2°C). Normal rat chow 
and water were provided ad libitum. The following day 
(gestational day 8) dams were placed on a normal rat 
chow supplemented with 2% cholesterol to suppress 
cholesterol synthesis by the liver. 
Between 1O:OO and 11:OO A.M.,  on gestational days 11, 
14, 16, 17, 18, 19, 20, and 22, one of the dams was 
injected intraperitoneally with 50-75 inCi [ 'Hlwater 
(ARC, St. Louis, MO).  After injection, dams were kept 
in a vented hood without further access to food and 
water for 4 h, after which they were lightly anesthetized 
with ether and killed by decapitation. Blood was col- 
lected from the aorta to obtain serum for determination 
of specific radioactivity of body water and for isolation 
of lipids. The abdomen was opened and both horns of 
the uterus were excised and rinsed with ice-cold physio- 
logical saline. Both horns of the uterus were opened 
longitudinally and the fetuses were peeled from the 
uterine lumen with their decidua and placenta intact 
and protected from evaporation by placement in plas- 
tic culture tubes on ice. Dissections were performed in 
Petri dishes on ice. Fetuses were separated from fetal 
membranes and weighed individually or as the pooled 
contents from each horn of the uterus. The decidua was 
separated from the placenta/ yolk sac and the amnion 
and umbilical cord were included with the latter. Indi- 
vidual tissues were isolated and rinsed with ice-cold 
physiological saline. ;I\verage weights were determined 
for individual organs either as the pooled contcnts l i o i i i  
each uterine horn i n  the early gt tional ages or 21s the 
pooled contents from 3-4 fetuses at later grstational 
ages. Fetuses before gestational day 14 did not ha\v ;I 
decidua and, therefore, each cmbryo was separated 
froni its placenta/yolk sac membranes. Livers w c r ~  oh- 
tained from fetuses at gestational age 16 and by gesla- 
tional day 18 other tissues (whole brain, heart, liings, 
and kidney) could be dissected intact. Blood was pooled 
from 4-5 fetuses beginning with gestational age 18. 
From each gestational age at least two fetuses were left 
intact for extraction of lipids in the whole fcttrs. 
Preparation and analyses of lipid extracts 
Total lipids were extracted from fetal tissues ac- 
cording to Folch, Lees, and Sloane Stanley (1 1 ) as niod- 
ified by Benjamins, Miller, and Morel1 (12), and sterols 
were quantitated as described previously ( 13). Briefly, 
free cholesterol was separated from its precursors and 
other lipids by reverse-phase HPLC on a C18 column 
(IXhosorb RP-18, Hewlett-Packard, Kennett Square, 
PA). Sterols were eluted isocratically at a flow rate of 2 
ml per min within 45 min with acetonitrile-isopropanol 
97.5:2.5 and were detected by absorbance at 210 nm. 
Adjusted (for void volume) retention times for choles- 
terol and the precursors of interest were as follows: 
squalene, 10.9 min; desmosterol/lanosterol, 19.2 min; 
7-dehydrocholesterol, 22.9 min; cholesterol, 31.5 min. 
Quaiititation of mass of sterols was made by comparing 
areas under sterol peaks to areas generated by known 
quantities of that sterol. Eluant fractions of 100 sec 
duration were collected during the elution period. Frac- 
tions were dried and resolubilized in 5 ml of Ecoscint 
H (Fisher, Raleigh, NC). Radioactivity in each fraction 
was determined in a Packard 1600TR Liquid Scintilla- 
tion Analyzer. Specific radioactivity could thus bc ob- 
tained very accurately as the same eluant fraction was 
used for assay of both inass and radioactivity. 
For some tissue samples a known quantity of the ex- 
tracted total lipid was subjected to alkaline hydrolysis t o  
determine cholesteryl ester content and radioactivity i n  
cholesterol moiety of the cholesteryl ester. The total 
lipid sample was dried under nitrogen and 2 ml of wa- 
ter-l0% KOH in methanol 1 : 1 was added. Samples 
were hydrolyzed for 4 h at 85°C: and at room tempera- 
ture overnight. Non-saponifiable lipids were isolated by 
the method of Folch et al. (1 1) and subjected to HPLC 
analysis as described above. The difference in free cho- 
lesterol contents before and after hydrolysis represents 
the quantity of cholesteryl ester in the total lipid sample. 
From the difference in radioactivities of free cholesterol 
before and after hydrolysis, the quantity of newly synthe- 
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sized cholesterol appearing as ester was calculated as 
described below. 
Experimental design 
The initial goal was to establish what fraction of cho- 
lesterol accumulating in the fetus is synthesized in the 
fetus, relative to the amount coming from the maternal 
circulation. Data needed include the rate of accumula- 
tion of total cholesterol in the fetus and rate of accumu- 
lation of newly synthesized cholesterol. The rate of cho- 
lesterol accumulation was obtained by assay of total 
cholesterol content of the fetus at various ages followed 
by calculation of the incremental accumulation of cho- 
lesterol. The rate of accumulation of newly synthesized 
cholesterol in the fetus was determined from the rate 
of incorporation of label from tritiated water into chc- 
lesterol. ["]water, injected into the dam several hours 
prior to killing, rapidly equilibrates with body pools of 
water in the dam and fetus and, subsequently, each mol- 
ecule of cholesterol synthesized de novo contains tri- 
tium with a stoichiometry defined by the biosynthetic 
pathway. As reviewed by Dietschy and Spady (5), 22 hy- 
drogens, equivalent to that originating from 11 mole- 
cules of water, are present in cholesterol. The amount 
of cholesterol synthesized during the 4 h (1/6th of a 
day) when [ 'Hlwater is present can be calculated from 
radioactivity present by assuming specific radioactivity 
of newly synthesized cholesterol is 11 times that of the 
body pool of water. Thus, the rate of appearance of 
newly synthesized cholesterol in any organ can be deter- 
mined by assay of radioactivity in cholesterol. 
nmoles cholesterol synthesized - - 
day 
6 X dpm in cholesterol in 4 h 
11 X dpm per nmole water 
If all the cholesterol present in the fetus is synthesized 
within the fetus, the rate of accumulation of cholesterol 
in the fetus should be equal to the rate of accumulation 
of newly synthesized cholesterol. The other extreme is 
if all of the cholesterol present in the fetus originates 
from the maternal circulation. In that case very little 
newly synthesized (radioactive) cholesterol would be 
present. This is because synthesis of cholesterol in the 
liver of the mother is suppressed by inclusion of 2% 
cholesterol in her diet, so little newly synthesized cho- 
lesterol is found in the maternal circulation. 
The experimental design, as applied to determi- 
nation of the source of cholesterol in various organs 
during postnatal development, is more extensively de- 
scribed in previous publications (13, 14); see also Belk- 
nap and Dietschy (6) for consideration of aspects spe- 
cific to the fetus. It must be verified that the timecourse 
of incorporation of label into cholesterol is linear and 
that the time needed for equilibration of precursor 
pools with the specific radioactivity of body water is ac- 
counted for. This time lag is, in fact, of the order of 30 
to 45 min if synthesis of cholesterol alone is considered 
(1 3). In preliminary studies related to the present work 
we showed that for maternal organs, this lag can be re- 
duced to several minutes if label accumulating in des- 
mosterol, lanosterol, and squalene is also taken into ac- 
count. This calculation involves expressing label in each 
of these intermediates as nmoles of intermediate syn- 
thesized. For example, synthesis of squalene involves in- 
corporation of 11 hydrogens from water (15) instead of 
the 22 required for cholesterol synthesis; each molecule 
of squalene synthesized is presumably committed to be- 
coming cholesterol and was, therefore, assumed to be 
equivalent to a molecule of cholesterol. We assumed 20 
atoms of hydrogen for labeling of desmosterol (present 
in brain) and 18 atoms of hydrogen incorporated into 
lanosterol, the primary intermediate present in other 
tissue. We did not correct for the lag time of equilibra- 
tion of maternal radioactive body water pools with fetal 
body water, a value shown to be of the order of 20 min 
for the rat fetus (6), and to that extent our calculation 
of locally synthesized cholesterol is a slight underesti- 
mate (see Discussion). 
The above experimental design is appropriate for 
evaluating overall cholesterol metabolism in the fetus, 
as feeding of cholesterol to the mother guarantees neg- 
ligible specific radioactivity of maternal circulating cho- 
lesterol (6, 13). Study of individual fetal tissues adds a 
second order of complexity in the analysis. Analysis of 
cholesterol biosynthesis by different fetal organs may be 
complicated if the specific radioactivity of circulating 
cholesterol is high. Thus, labeling of cholesterol in the 
fetal circulation must be determined, and accounted 
for in the calculations. 
RESULTS 
Organ weight and cholesterol content 
The wet weights of whole fetus and of various dis- 
sected organs are plotted as a function of gestational 
age (Fig. 1 ) .  As expected, more than three-quarters of 
the growth of the whole fetus and tissues of fetal origin 
(placenta/yolk sac) takes place at or after the eigh- 
teenth day of gestation. This contrasts with the growth 
of the uterus and decidua (tissues of maternal origin) 
which attain full size by gestational age 18. The data for 
cholesterol accumulation by organ is also available (Fig. 
2) and track net weight reasonably well. Calculations 
from the data presented in these figures demonstrate 
that the organ-specific differences in cholesterol con- 
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Fig. 1. Wet weight of whole uterus after removal of fetuses and deciduae. Other tissues are on a per fetus 
basis; these include the decidua (of maternal origin) and the placenta/yolk sac (of fetal origin). The fetus 
was further dissected to obtain the tissues noted on the right-hand graph. On this and subsequent graphs, 
experimental points are single observations unlcss otherwise indicated. Where present, error bars represent 
a standard deviation for triplicate values 
centration before birth are small; for example, at gesta- 
tional age 22 days the concentrations of cholesterol in 
liver, kidney, and brain, respectively, are: 4.05, 5.9, and 
7.1 nmol/mg wet weight. In contrast, by postnatal day 
35 the cholesterol concentration in these three tissues 
is 3.2, 8.3, and 36.4 nmol/mg wet weight, respectively 
(H. Jurevics and P. Morell, unpublished data from our 
laboratory). 
The plateau in weight gain of the uterus before the 
time of maximum size increase of the fetus is well docu- 
mented (16), and the actual slight decline in choles- 
terol after 19 days is not unexpected. Late in gestation 
there are hormonally mediated structural changes in 
the uterus leading to a decrease in smooth muscle cell 
size (16) and an increase in protease activity (17) that 
could also be accompanied by a loss of tissue choles- 
terol. Similar results have been reported for decidua; 
this structure forms from the endometrial cells of the 
uterine stroma to make a thick capsule around the im- 
planted embryo. As pregnancy approaches term there 
is cell death in the decidua with a gradual thinning of 
the tissue (1 8). 
Because conversion of cholesterol to cholesteryl ester 
is a potential complication in interpretation of our ana- 
lytical data, we assayed each tissue for cholesteryl ester 
content as a fraction of total cholesterol at 17, 19, and 
22 days of age. Radioactivity in the cholesterol moiety of 
the cholesteryl esters was also determined. A significant 
level of cholesteryl ester was found in maternal serum: 
55% of total cholesterol was present as the ester but, in 
these cholesterol-fed animals, there was no significant 
amount of radioactive labeling of any cholesterol in the 
maternal circulation. For fetal serum, 20% of the total 
cholesterol was present as ester at 17 d, increasing to 
35% at 22 d; at these ages only about 5% of the label 
in total cholesterol was present in the cholesterol moi- 
ety of the ester. In uterus, about 26% of cholesterol was 
present as ester but this contained 16% of label at 17 
d and less than 1% by 22 d. In fetal liver, 40-15% of 
cholesterol was present as ester between 17 and 22 days 
and, correspondingly, 10% and 5% of label was present 
in the cholesterol moiety of cholesteryl ester. In the 
placenta/yolk sac about 25% of cholesterol was present 
as the ester at the three ages and, as cholesterot synthe- 
sis in this organ system decreased with development, the 
fraction of label present in cholesteryl ester decreased 
from 14% to less than 1%. 
Cholesterol labeling in the serum 
For label in fetal cholesterol to be equated with fetal 
synthesis of cholesterol, it must be known that specific 
radioactivity of maternal circulating cholesterol is negli- 
gible. We first determined cholesterol concentration in 
the serum of darn and fetus (Fig. 3A). Note the rise in 
maternal serum cholesterol later in gestation, similar to 
that previously reported for humans (19) and rat (20). 
The levels of cholesterol in fetal serum are at this higher 
level. However, as indicated by the data below, there is 
not a precursor product relationship between the two 
pools of cholesterol. 
The plot in Fig. 3B represents the fraction of choles- 
terol in the serum of the dam and fetus that was synthe- 
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Fig. 2. 
in Fig. 1. Three to five fetal tissues were pooled for each assay. 
Cholesterol content of whole uterus and various fetal tissues corresponding to the samples described 
sized during the 4 h  labeling period. Note that this is 
actually a plot of corrected specific radioactivity; the 
value for radioactivity (presented as newly synthesized 
cholesterol according to the equation given previously) 
is divided by bulk free cholesterol. For serum in the ma- 
ternal circulation, much less than l % of the circulating 
cholesterol is newly synthesized. This is as expected be- 
cause synthesis of cholesterol in the maternal liver is 
suppressed by cholesterol feeding, and any newly syn- 
thesized cholesterol is initially diluted by the liver pool 
of cholesterol and then by cholesterol already in the 
maternal circulation. Thus, with regard to the data pre- 
sented in subsequent figures, the specific radioactivity 
of cholesterol, cholesteryl esters, and cholesterol pre- 
cursor in the maternal circulation is much too low to 
account for any significant accumulation of radioactiv- 
ity in the fetus. 
The data for specific radioactivity of serum choles- 
terol in the fetus (Fig. 3B) contrasts with that for mater- 
nal serum cholesterol. After the 4 h  labeling period, 
16% of the fetal circulating cholesterol is newly synthe- 
sized. This is presumably a function of failure of dietary 
cholesterol to suppress cholesterol synthesis in fetal 
liver, a smaller pool of liver cholesterol for dilution 
prior to release into the circulation, and the expected 
more rapid turnover of circulating cholesterol as it con- 
tinues to be removed by many of the rapidly growing 
organs. The specific radioactivity of circulating fetal 
cholesterol is high enough so that it is a consideration 
when evaluating cholesterol trafficking within the fetus 
(see last section of Results). In fetal serum, lanosterol 
was the only cholesterol precursor found to have sig- 
nificant radiolabel after 4 h. The distribution was 93.9 
? 2.1 (SD)% in cholesterol and 6.1 ? 2.1 (SD)% in 
lanosterol. This distribution is similar in serum of rats 
weaned onto a cholesterol-free diet where cholesterol 
in serum is labeled significantly (1 3).  
Cholesterol balance in whole fetus compared to that 
of the maternal uterus 
The rate of synthesis of fetal cholesterol is similar to 
the rate of accumulation of fetal cholesterol (Fig. 4A). 
The amount of cholesterol newly synthesized each day 
was summed between gestational days 11 and 22, and 
the value was compared to the total amount of choles- 
terol in the 22-day-old fetus. We found that at least 93% 
of the cholesterol accumulating in the fetus was newly 
synthesized (see Discussion). As contribution of radio- 
active cholesterol from maternal circulation is negligi- 
ble (shown above) it is apparent that most of the choles- 
terol in the fetus is synthesized by fetal cells. The 
possibility that the maternal liver synthesizes a lipopro- 
tein with a high specific radioactivity and that the cho- 
lesterol in this lipoprotein travels undiluted by pre-ex- 
isting pools of this lipoprotein cannot be dismissed 
entirely but appears highly speculative considering our 
present knowledge of circulating lipoproteins. 
A dramatic contrast to the above results for fetus is 
offered by the data for the uterus (Fig. 4B) and decidua 
(Fig. 4D). Most of the cholesterol accumulating in these 
maternally derived tissues is unlabeled and therefore, 
as expected, comes from the maternal circulation. The 
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Fig. 3. Cholesterol concentration and appearance of newly synthesized cholesterol in serum of dam and fetus 
4 h after injecting the darn with ['lH]water. Cholesterol content and radiolabel in cholesterol were determined 
by HPLC as described in Methods. Cholesterol concentration is plotted in panel A. For panel B the ordinate 
units correspond to percentage of the total circulating cholesterol that is newly synthesized; this calculation 
is based on the assumption (see Experimental Design Section) that 22 atoms of H are incorporated per mole- 
cule of cholesterol, thus allowing for normalization of differences among animals in specific radioactivity of' 
body water. All values are from a single assay of serum from one dam at each time point and the pooled serum 
from 4-5 fetuses at each gestational age. 
time-course of cholesterol accumulation in uterus and 
decidua is very different from that of the fetus, with the 
actual loss of tissue at the end of gestation accounting 
for the loss of cholesterol at the last age point. 
Data for placenta/yolk sac (Fig. 4C) indicate a mass 
and rate of cholesterol accumulation of the order of 
10% of that of the fetus. The slight excess of synthesis 
of cholesterol over its accumulation occurring after ges- 
tational day 18 was less than 0.2 pmol per day suggesting 
a maximal possible contribution of only a few percent 
to the fetus, which is accumulating cholesterol at a rate 
of several pmol a day. The contribution is, in fact, even 
less as some of this excess newly synthesized cholesterol 
may be used to account for the synthesis of cholesteryl 
ester; the cholesteryl ester content of placenta/yolk sac 
is 25 2 5% (SD) of total cholesterol. It is also possible 
that a minor source of error contributing to the overall 
sterol balance would be production of steroid hor- 
mones and/or bile acids by the fetus. 
Cholesterol balance for brain and liver 
During development of the fetal brain, the rate of 
accumulation of bulk cholesterol is similar to the rate 
of accumulation of' newly synthesized cholesterol (Fig. 
5A). Thus, unless the specific radioactivity of fetal se- 
rum cholesterol is very high (which is not the case, see 
Fig. 3),  this is evidence that the cholesterol in fetal brain 
is locally synthesized. The results for the fetal liver (Fig. 
5B) stand in marked contrast. At the earliest age at 
which we could clearly dissect and analyze liver, and 
proceeding through to birth, the liver synthesizes a 
great deal more cholesterol than is required for growth 
of this organ. During early development of the liver, 
before gestational day 19, 40% of the cholesterol in 
the liver is in the ester form, but this declines to less 
than 15% of total cholesterol by gestational day 22. 
Thus, during early development, we calculated that, 
of the newly synthesized cholesterol, 30% accumul- 
ates as free-cholesterol, 16% is converted to ester, 
and the remaining 44% is exported from the liver. 
Over the course of gestational development, the 
liver synthesizes 1.7 pmol of cholesterol in excess of 
that accumulating. The assumption that this cholesterol 
is exported to the fetal circulation and used by 
other tissues is supported by experiments described 
below. 
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Fig. 4. Accumulation of bulk cholesterol and accumulation of newly synthesized cholesterol in various organs. 
The accumulation of bulk cholesterol is calculated from the data in Fig. 2. The newly synthesized cholesterol 
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Cholesterol balance during development of kidney, 
heart, and lung 
With respect to data for individual organs of the fetus, 
in order to equate radioactivity present with locally syn- 
thesized cholesterol one would have to assume negligi- 
bly low entry of label from the circulation and, there- 
fore, negligibly low specific radioactivity of fetal serum 
cholesterol. This is not the case (Fig. 3B). Thus, in anal- 
ysis of these data, a calculation is required to determine 
how much of the newly synthesized cholesterol was lo- 
cally synthesized. A first order correction for the accu- 
mulation of radioactive cholesterol in each organ was 
obtained by subtraction of radioactivity corresponding 
to synthesis of 8% of the accumulation of unlabeled 
cholesterol. (The fraction of radioactivity in imported 
cholesterol was set at 8% rather than 16% to account 
for the linear increase in radioactive cholesterol in the 
blood during the time period studied.) These corrected 
values are shown as the third bar in histograms of Fig. 
6. As is evident, the first order correction is slight (a 
complete correction is not possible algebraically with- 
out further assumptions but would be negligible in view 
of the relatively low specific radioactivity of serum cho- 
lesterol). It is clear that for heart (Fig. 6A), kidney (Fig. 
6B), and lung (Fig. 6C), the rate of accumulation of 
cholesterol is considerably faster than can be accounted 
for by appearance of newly synthesized cholesterol. 
Thus, half or more of the cholesterol accumulating is 
unlabeled and presumably comes from the fetal circula- 
tion. For all three organs combined, less than 1 pmol 
of cholesterol is accumulated by gestational day 22. This 
amount is considerably less than the excess of choles- 
terol synthesized by the liver. The proportion of choles- 
terol for development supplied by the fetal circulation 
may be quite small in other organs. For example, in 
other experiments (data not shown) by 22 days the 
amount of cholesterol accumulated by the urogenital 
system, stomach, intestines, and pancreas, combined, 
was 1.7 pmol of which 80% was accounted for by newly 
synthesized cholesterol. 
DISCUSSION 
The concept of measuring cholesterol synthesis 
within the fetus by determination of label incorporated 
from radioactive water into cholesterol was introduced 
by Belknap and Dietschy in 1988 (6). They demon- 
strated that [ 'HI water administered intravenously to 
the mother rapidly equilibrates with the body pool of 
water and that (as that laboratory had previously 
showed in adults (4)),  22 hydrogen atoms from the 
body water pool were incorporated into each molecule 
of newly synthesized cholesterol. When calculated per 
gram of tissue for various organs, the rate of synthesis 
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Fig. 5. Accumulation of hulk cholesterol and newly synthesized cholesterol during growth of. fetal brain and 
liver. Accumulation of bulk cholesterol was calculated from the data in Fig. 2 and that in newly synthesized 
cholesterol from incorporated radioactivity from [”Hlwater as detailed in Experimental Design Section. The 
error bars for brain correspond to data from the samples described in Fig. 2. 
of cholesterol was several times greater in the rat fetus 
than in the dam, suggesting that much of the demand 
for cholesterol for fetal growth was met by the fetus. 
This conclusion received further support when feeding 
cholesterol to the mother greatly lowered the specific 
radioactivity of maternal circulating cholesterol but did 
not significantly change incorporation of label into fe- 
tal cholesterol. Furthermore, there was no transfer of 
‘251-labeled cellobiose-labeled lipoprotein from mater- 
nal circulation to the fetus. These authors concluded 
“that the rat fetus receives little or no cholesterol from 
the mother but, rather, satisfies its need for cholesterol 
during fetal development through local synthesis.” 
Our experimental design is based on that of Belknap 
and Dietschy (6), but also included quantitation of the 
developmental increase in fetal cholesterol, making i t  
possible to calculate a specific radioactivity for newly 
synthesized cholesterol. Thus, we are able to make a 
quantitative statement that at least 93% of the choles- 
terol accumulating in the fetus during development is 
of fetal origin. This is probably a 4% underestimate, be- 
cause we did not correct for the approximately 20 min 
lag in the equilibration of label with fetal body water 
(6) that would lead to a consequently slight underesti- 
mation of the rate of cholesterol synthesis. Thus, inas- 
much as our data were interpreted in terms of source 
of cholesterol in the whole fetus, our results are in ac- 
cord with the conclusions of Belknap and Dietschy (6). 
We acknowledge, however, the existence of data from 
other laboratories interpreted to give conclusions con- 
trary to ours (discussed below). 
Transfer of labeled cholesterol from mother to fetus 
was first reported in rat in 1947 by Goldwater and Stet- 
ten (21). Studies on guinea pigs (1) and rhesus mon- 
keys (2) demonstrated that [ ‘“C] cholesterol in the dam 
equilibrated with fetal cholesterol at a rate suggesting 
significant uptake of maternal cholesterol by the fetus 
(with the exception of fetal brain). Placental involve- 
ment was suggested as this structure is capable of uptake 
of high density lipoproteins, very low density lipopro- 
tein, and low density lipoprotein cholesterol (6,22) and 
contains lipoprotein receptors that bind lipoprotein 
particles carrying apolipoprotein E (23). There is also 
evidence for transplacental transport of low density 
lipoprotein-bound cholesterol by human placenta in 
vitro (24), and synthesis of apolipoprotein B (presum- 
ably for formation of lipoprotein particles) by yolk sac 
has been reported (25-27). The cholesterol carried by 
these lipoprotein particles might be for transfer of ma- 
ternally or locally derived (placenta/ yolk sac) choles- 
terol to the fetus and/or might serve as substrate for 
placental progesterone synthesis (28). These lipopro- 
tein particles also serve as a source of essential free fatty 
acids and lipid-soluble vitamins for the developing fetus 
(for reviews, see 29-31). The yolk sac may play a role 
in processing of lipoidal material transferred from ma- 
ternal circulation to the developing fetus, as evidenced 
by developmental growth retardation of rat fetus upon 
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calculated as described in the text. 
exposure to antibodies to the yolk sac (32). Relevant 
also is the embryonic lethality of mice homozygous for 
deletion of the apolipoprotein B gene (33, 34); this 
apolipoprotein is normally secreted by both the yolk sac 
(26) and fetal liver (25). 
A quantitative study, which concludes that maternal 
cholesterol may be at least indirectly involved in fetal 
cholesterol metabolism, is reported by Woollett (3). 
This author, also studying incorporation of label from 
['HI water into cholesterol, concluded that only 40% of 
cholesterol accumulating during fetal development of 
the hamster was synthesized by the fetus. She also stud- 
ied incorporation by fetal tissues of '251-labeled cellobi- 
ose-labeled lipoproteins from the maternal circulation. 
Her data, similar to that obtained for the rat fetus by 
Belknap and Dietschy (6), indicated that although the 
fetus incorporated maternally derived '251-labeled cello- 
biose-labeled lipoproteins into placenta and yolk sac, 
no radioactivity reached the fetus. However, the conclu- 
sion reached by Woollett (3) differs from that of Belk- 
nap and Dietschy (6); she proposed that the 60% deficit 
of cholesterol in the fetus could be made up by transfer 
to the fetus of maternal cholesterol or cholesterol from 
yolk sac and placenta; the loss of cholesterol from 
placenta/yolk sac being compensated for by uptake 
from the maternal circulation. Woollett (3) also recal- 
culated the data of Belknap and Dietschy (6). With cer- 
tain assumptions (similar to our own) regarding synthe- 
sis of cholesterol from ['Hlwater, she concluded in that 
study also that locally synthesized cholesterol could only 
account for about half the cholesterol accumulating in 
the fetus during development. Thus, it appears that 
Woollett and Belknap and Dietschy obtained similar re- 
sults in hamster and rat, respectively, but interpreted 
the data differently. 
The rate of fetal cholesterol synthesis we calculated 
is greater than those found by the above two groups of 
investigators; our data show synthesis within the fetus 
is sufficient to account for almost all the accumulated 
cholesterol. While we do not have a definitive explana- 
tion for the differences in results between laboratories, 
one explanation is that different times of exposure to 
[ 'HI water were used prior to assay of label incorporated 
into cholesterol. Both Woollett, and Belknap and 
Dietschy, used a 1-h incubation period while we used a 
4 h  incubation. In previous studies (13) we had found 
that a lag period of 30 to 45 min occurred before the 
incorporation of radiolabel in cholesterol became lin- 
ear with time; presumably because of a lag in equilibra- 
tion of label in body water and pools of cholesterol pre- 
cursors. It is possible that radiolabel in [3H] sterol after 
an hour of incubation may underestimate cholesterol 
biosynthesis because all precursor pools may not be ra- 
diolabeled at the same rate; such an error would be 
much less with our 4 h  labeling period. 
Another possible reason for the discrepancies of our 
Fig. 6. Accumulation of bulk cholesterol and newly synthesized cholesterol in fetal heart, kidney, and lung. 
Accumulation was calculated from data in Fig. 2 while newly synthesized cholesterol was determined from 
incorporation of radioactivity from [3H]water as detailed in Experimental Design Section. A third value, the 
fraction of newly synthesized cholesterol that was made within the tissue in question (locally synthesized), was 
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data in rat, relative to that obtained for hamster ( 3 ) ,  is 
species differences. It has been proposed (Woollett) 
that, in the hamster, there is considerable contribution 
to the fetus of cholesterol synthesized by the placenta/ 
yolk sac. This explanation may be relevant to the ham- 
ster ( 3 )  where the proportional size of the placenta/ 
yolk sac, as well as concentration of cholesterol seem to 
be greater than the corresponding values we obtain for 
rat. Thus, at term, the content of cholesterol in hamster 
placenta/yolk sac is almost half of that in the fetus ( 3 )  
while our  values for rat indicate that placenta/yolk sac 
has less than 10% of the cholesterol content of fetus. 
We also note that although the experimental design 
we utilized is based on that of Belknap and Dietschy, 
the analytical techniques used differ greatly. Belknap 
and Dietschy (6) and Woollett (3) assayed sterol as dig- 
itonin-precipitable material. We utilized HPLC tech- 
niques that clearly separate from each other the differ- 
ent sterols and their metabolic precursors. 'This allows 
for identification and quantitation of each sterol, and 
for a more exact determination of how much 01' each 
sterol is newly synthesized, as incorporation of label 
from water could be correlated with knowledge about 
metabolic pathways for synthesis of individual sterols. 
In any case, our data permit only one simple interpreta- 
tion, that the rat fetus synthesizes almost all of its own 
cholesterol. 
We were also able to devise techniques to extend 
[:'HI water methodology to study of cholesterol balance 
among different fetal organs. As when working with the 
adult animal (13, 14) the assumption is that cholesterol 
accumulating in any particular organ is either locally 
synthesized or  has come from the circulation. A note- 
worthy result we obtained is that the developing fetal 
brain appears almost completely dependent on local 
synthesis of cholesterol. Whatever barriers to the circu- 
lation are involved in preventing entry into brain and 
utilization of circulating cholesterol in the adult are al- 
ready present during the period of rapid fetal brain 
growth (18-22 days of gestation). W7e have thus ex- 
tended to the fetal period the observation that, postna- 
tally, most of the cholesterol for brain development is 
locally synthesized (14, 35 and references contained 
therein). Our data are compatible with those of Turley 
et al. (36) who showed that fetal sheep brain does not 
clear low density lipoprotein from the fetal circulation, 
again suggesting circulating cholesterol does not enter 
brain. These results suggest that the failure of the ner- 
vous system to develop normally, due to the defect in  
cholesterol biosynthesis characteristic of Smith-Lemli- 
0pit-Z syndrome (7-IO), is unlikely to be treatable by 
cholesterol supplementation of maternal diet or  even 
by direct delivery of cholesterol to the fetal circulation. 
It is also interesting that by 16 days gestation, the fetal 
liver already plays a major role in exporting cholesterol 
t o  other organs. This cholesterol is used t o  nicct ahout 
half of thc demand for cholesterol by heart, lung, and 
kidney. Although other tissues also take up circulating 
cholesterol, many ofthem must do so to a Iesscr cxtent. 
Calculations based on the data i n  Fig. 5 show that from 
16 days upward the overall amount of excess cholesterol 
synthesized by liver, presumably dedicated to cxport, is 
less than 2 pmol. As there is a 15 pmol gain in to~al  
fetal cholesterol, we concluded that, even though heart, 
lung, and kidney obtain significant amounts of' choles- 
terol initially produced by the fetal liver, many othet 
tissues of fetus make most of their own cholesterol. 
The above data are compatible with studies of rnRNA 
expression for genes involved in Cholesterol biosynthe- 
sis; liver, kidney, lung, and brain all express these tiles- 
sages at  near-maximal levels during late gestation (37) .  
After birth, as the rat suckles on the high cholesterol 
content milk, message levels for enqmes in the biosyn- 
thetic pathway are rapidly and greatly reduced i n  liver, 
not affected in brain, and decline to intermediate levels 
in other organs. Similar patterns were obtained for en- 
zyme activity by direct biochemical assay of HMG-CoA 
reductase (38 ) ,  a mzijor control point in cholesterol bio- 
synthesis. 
The methodology we describe allows for quantitative 
assessment of cholesterol trafficking in the fetus. I t  gives 
useful information concerning fetal nutrition and is ap- 
plicable to studies of other Substrates of fetal growth 
(e.$., origin of fatty acids in fetal lipids). It could also 
provide a sensitive test as to whether metabolic pertur- 
bations, such as administration of a therapeutic drug 
(for example, for hypercholesterolemia), could affect 
fetal metabolism of cho1esteroLil 
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